Mesenchymal stem cell membrane-coated kaempferol biomimetic nanoformulation for the treatment of atherosclerosis
APL Bioengineering · 01.03.2026 · 10 (1)
DOI: 10.1063/5.0303756 ↗Kurz gefasst
Fachartikel in der Zeitschrift APL Bioengineering, online erschienen am 26.02.2026. Verfasst von Qianting Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Panvascular Biology, JinFeng Laboratory, Chongqing 401329, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Innovation Project of Jinfeng Laboratory, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Atherosclerosis and its complications are highly prevalent worldwide, and managing oxidative stress in endothelial cells to alleviate abnormal inflammatory damage is a critical therapeutic approach. Nanomedicine delivery systems offer promising solutions by overcoming the limitations of surgical interventions and the off-target effects of oral drugs. In this study, we developed a modified mesenchymal stem cell membrane (MSCM)-encapsulated nanoparticle drug delivery system that effectively delivers kaempferol to atherosclerotic sites. These biomimetic nanoparticles were able to specifically target endothelial cells in an inflammatory environment while evading macrophage-mediated endocytosis. Moreover, the modified MSCM-encapsulated kaempferol nanoparticles (KPM) had a protective effect on oxidatively damaged endothelial cells. In vivo, the modified nanoparticles successfully migrated toward atherosclerotic lesions, as demonstrated in a mouse model of susceptible atherosclerotic plaques. Intravenous injection of KPM significantly reduced the lipid plaque load and improved plaque structure. Furthermore, the biosafety of KPM was comprehensively assessed both in vitro and in vivo, with no significant effects on blood count, lipid balance, cellular activity, body weight, or liver or kidney function. This is the first report of the use of MSCM to encapsulate kaempferol nanodrugs to treat atherosclerosis. This strategy presents a novel and effective therapeutic system for targeted delivery of antioxidant therapy to atherosclerotic sites, offering potential for the treatment of atherosclerosis in cardio-cerebrovascular diseases.
Autor:innen und Institutionen
- Institute of Panvascular Biology, JinFeng Laboratory, Chongqing 401329, China.
- Institute of Medicine, Taiji Group Co., Ltd., Chongqing 401121, China.
- Chongqing University Cancer Hospital, Chongqing 400030, China.
- Institute of Cytology, Russian Academy of Science, Tikhoretskiy Prospect 4, 194064 St. Petersburg, Russia.
ORCID-Profile: Xiangxiu Wang, Anna Malashicheva, Chuanrong Zhao, Guixue Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Innovation Project of Jinfeng Laboratory
- Fundamental Research Funds for the Central Universities
- Chongqing Traditional Chinese Medicine Innovation Team Construction Project
- Chongqing Science and Technology Joint Medical Research Project
Zitieren
APA
Zhang, Q., Wang, X., Zhang, H., He, K., Pu, D., Chen, H., Malashicheva, A., Han, W., Zhao, C., & Wang, G. (2026). Mesenchymal stem cell membrane-coated kaempferol biomimetic nanoformulation for the treatment of atherosclerosis. APL Bioengineering, 10(1). https://doi.org/10.1063/5.0303756
Vancouver
Zhang Q, Wang X, Zhang H, He K, Pu D, Chen H, et al. Mesenchymal stem cell membrane-coated kaempferol biomimetic nanoformulation for the treatment of atherosclerosis. APL Bioengineering. 2026;10(1). doi:10.1063/5.0303756
BibTeX
@article{Zhang2026,
author = {Zhang, Qianting and Wang, Xiangxiu and Zhang, Hongping and He, Keqiao and Pu, Daojun and Chen, Hong and Malashicheva, Anna and Han, Wenbo and Zhao, Chuanrong and Wang, Guixue},
title = {Mesenchymal stem cell membrane-coated kaempferol biomimetic nanoformulation for the treatment of atherosclerosis},
journal = {APL Bioengineering},
year = {2026},
volume = {10},
number = {1},
doi = {10.1063/5.0303756}
}
EUVIMED